Stockreport

Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human [Yahoo! Finance]

Eledon Pharmaceuticals, Inc.  (ELDN) 
PDF Tegoprubart administration has now been used investigationally to prevent rejection in both kidney and heart pig-to-human xenotransplantations, as well as in human-to-h [Read more]